These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
211 related articles for article (PubMed ID: 21810436)
21. Inhibition of thymidine phosphorylase expression by using an HSP90 inhibitor potentiates the cytotoxic effect of cisplatin in non-small-cell lung cancer cells. Weng SH; Tseng SC; Huang YC; Chen HJ; Lin YW Biochem Pharmacol; 2012 Jul; 84(1):126-36. PubMed ID: 22480737 [TBL] [Abstract][Full Text] [Related]
22. Down-regulation of ERK1/2 and AKT-mediated X-ray repair cross-complement group 1 protein (XRCC1) expression by Hsp90 inhibition enhances the gefitinib-induced cytotoxicity in human lung cancer cells. Tung CL; Jian YJ; Syu JJ; Wang TJ; Chang PY; Chen CY; Jian YT; Lin YW Exp Cell Res; 2015 May; 334(1):126-35. PubMed ID: 25662161 [TBL] [Abstract][Full Text] [Related]
23. Curcumin downregulates p38 MAPK-dependent X-ray repair cross-complement group 1 (XRCC1) expression to enhance cisplatin-induced cytotoxicity in human lung cancer cells. Tung CL; Jian YJ; Chen JC; Wang TJ; Chen WC; Zheng HY; Chang PY; Liao KS; Lin YW Naunyn Schmiedebergs Arch Pharmacol; 2016 Jun; 389(6):657-66. PubMed ID: 27026405 [TBL] [Abstract][Full Text] [Related]
24. Induction of Rad51 protein levels by p38 MAPK decreases cytotoxicity and mutagenicity in benzo[a]pyrene-exposed human lung cancer cells. Chuang SM; Wang LH; Hong JH; Lin YW Toxicol Appl Pharmacol; 2008 Aug; 230(3):290-7. PubMed ID: 18430445 [TBL] [Abstract][Full Text] [Related]
25. Docosahexaenoic acid induces apoptosis in lung cancer cells by increasing MKP-1 and down-regulating p-ERK1/2 and p-p38 expression. Serini S; Trombino S; Oliva F; Piccioni E; Monego G; Resci F; Boninsegna A; Picci N; Ranelletti FO; Calviello G Apoptosis; 2008 Sep; 13(9):1172-83. PubMed ID: 18679798 [TBL] [Abstract][Full Text] [Related]
26. Astaxanthin enhances pemetrexed-induced cytotoxicity by downregulation of thymidylate synthase expression in human lung cancer cells. Liao KS; Wei CL; Chen JC; Zheng HY; Chen WC; Wu CH; Wang TJ; Peng YS; Chang PY; Lin YW Regul Toxicol Pharmacol; 2016 Nov; 81():353-361. PubMed ID: 27693704 [TBL] [Abstract][Full Text] [Related]
27. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB. Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544 [TBL] [Abstract][Full Text] [Related]
28. Down-regulation of Sprouty2 in non-small cell lung cancer contributes to tumor malignancy via extracellular signal-regulated kinase pathway-dependent and -independent mechanisms. Sutterlüty H; Mayer CE; Setinek U; Attems J; Ovtcharov S; Mikula M; Mikulits W; Micksche M; Berger W Mol Cancer Res; 2007 May; 5(5):509-20. PubMed ID: 17510316 [TBL] [Abstract][Full Text] [Related]
29. Ginsenosides synergize with mitomycin C in combating human non-small cell lung cancer by repressing Rad51-mediated DNA repair. Zhao M; Wang DD; Che Y; Wu MQ; Li QR; Shao C; Wang Y; Cao LJ; Wang GJ; Hao HP Acta Pharmacol Sin; 2018 Mar; 39(3):449-458. PubMed ID: 28836581 [TBL] [Abstract][Full Text] [Related]
30. Prostaglandin E2 activates mitogen-activated protein kinase/Erk pathway signaling and cell proliferation in non-small cell lung cancer cells in an epidermal growth factor receptor-independent manner. Krysan K; Reckamp KL; Dalwadi H; Sharma S; Rozengurt E; Dohadwala M; Dubinett SM Cancer Res; 2005 Jul; 65(14):6275-81. PubMed ID: 16024629 [TBL] [Abstract][Full Text] [Related]
31. Inhibition of pancreatic and lung adenocarcinoma cell survival by curcumin is associated with increased apoptosis, down-regulation of COX-2 and EGFR and inhibition of Erk1/2 activity. Lev-Ari S; Starr A; Vexler A; Karaush V; Loew V; Greif J; Fenig E; Aderka D; Ben-Yosef R Anticancer Res; 2006; 26(6B):4423-30. PubMed ID: 17201164 [TBL] [Abstract][Full Text] [Related]
33. Curcumin-induced apoptosis in ovarian carcinoma cells is p53-independent and involves p38 mitogen-activated protein kinase activation and downregulation of Bcl-2 and survivin expression and Akt signaling. Watson JL; Greenshields A; Hill R; Hilchie A; Lee PW; Giacomantonio CA; Hoskin DW Mol Carcinog; 2010 Jan; 49(1):13-24. PubMed ID: 19676105 [TBL] [Abstract][Full Text] [Related]
34. Tamoxifen enhances erlotinib-induced cytotoxicity through down-regulating AKT-mediated thymidine phosphorylase expression in human non-small-cell lung cancer cells. Ko JC; Chiu HC; Syu JJ; Jian YJ; Chen CY; Jian YT; Huang YJ; Wo TY; Lin YW Biochem Pharmacol; 2014 Mar; 88(1):119-27. PubMed ID: 24447935 [TBL] [Abstract][Full Text] [Related]
35. Inhibition of the Raf-MEK1/2-ERK1/2 signaling pathway, Bcl-xL down-regulation, and chemosensitization of non-Hodgkin's lymphoma B cells by Rituximab. Jazirehi AR; Vega MI; Chatterjee D; Goodglick L; Bonavida B Cancer Res; 2004 Oct; 64(19):7117-26. PubMed ID: 15466208 [TBL] [Abstract][Full Text] [Related]
36. Expression of 1-cys peroxiredoxin in the corneal wound-healing process. Pak JH; Choi HJ; Choi CY; Tchah H Cornea; 2006 Dec; 25(10 Suppl 1):S29-35. PubMed ID: 17001189 [TBL] [Abstract][Full Text] [Related]
37. Oncogenic tyrosine kinase NPM/ALK induces activation of the MEK/ERK signaling pathway independently of c-Raf. Marzec M; Kasprzycka M; Liu X; Raghunath PN; Wlodarski P; Wasik MA Oncogene; 2007 Feb; 26(6):813-21. PubMed ID: 16909118 [TBL] [Abstract][Full Text] [Related]
38. Curcumin enhances Vinorelbine mediated apoptosis in NSCLC cells by the mitochondrial pathway. Sen S; Sharma H; Singh N Biochem Biophys Res Commun; 2005 Jun; 331(4):1245-52. PubMed ID: 15883009 [TBL] [Abstract][Full Text] [Related]
39. Activation of nonsteroidal anti-inflammatory drug-activated gene-1 via extracellular signal-regulated kinase 1/2 mitogen-activated protein kinase revealed a isochaihulactone-triggered apoptotic pathway in human lung cancer A549 cells. Chen YL; Lin PC; Chen SP; Lin CC; Tsai NM; Cheng YL; Chang WL; Lin SZ; Harn HJ J Pharmacol Exp Ther; 2007 Nov; 323(2):746-56. PubMed ID: 17715378 [TBL] [Abstract][Full Text] [Related]
40. Pir51, a Rad51-interacting protein with high expression in aggressive lymphoma, controls mitomycin C sensitivity and prevents chromosomal breaks. Henson SE; Tsai SC; Malone CS; Soghomonian SV; Ouyang Y; Wall R; Marahrens Y; Teitell MA Mutat Res; 2006 Oct; 601(1-2):113-24. PubMed ID: 16920159 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]